These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24607013)

  • 1. Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil.
    Cipriano G; Neves LM; Cipriano GF; Chiappa GR; Borghi-Silva A
    Prog Cardiovasc Dis; 2014; 56(5):493-500. PubMed ID: 24607013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in reducing cardiovascular risk factors in the United States: focus on worksite health and wellness.
    Cahalin LP; Myers J; Kaminsky L; Briggs P; Forman DE; Patel MJ; Pinkstaff SO; Arena R
    Prog Cardiovasc Dis; 2014; 56(5):476-83. PubMed ID: 24607011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worksite health and wellness programs: Canadian achievements & prospects.
    Després JP; Alméras N; Gauvin L
    Prog Cardiovasc Dis; 2014; 56(5):484-92. PubMed ID: 24607012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle modification interventions and cardiovascular health: global perspectives on worksite health and wellness and cardiac rehabilitation.
    Arena R
    Prog Cardiovasc Dis; 2014; 56(5):473-5. PubMed ID: 24607010
    [No Abstract]   [Full Text] [Related]  

  • 5. Worksite health and wellness in the European union.
    Guazzi M; Faggiano P; Mureddu GF; Faden G; Niebauer J; Temporelli PL
    Prog Cardiovasc Dis; 2014; 56(5):508-14. PubMed ID: 24607015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worksite health and wellness programs in India.
    Babu AS; Madan K; Veluswamy SK; Mehra R; Maiya AG
    Prog Cardiovasc Dis; 2014; 56(5):501-7. PubMed ID: 24607014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worksite wellness for the primary and secondary prevention of cardiovascular disease in Japan: the current delivery system and future directions.
    Okamura T; Sugiyama D; Tanaka T; Dohi S
    Prog Cardiovasc Dis; 2014; 56(5):515-21. PubMed ID: 24607016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Implementation of Worksite Health and Wellness Programs: A Focus on Non-Communicable Disease.
    Cahalin LP; Kaminsky L; Lavie CJ; Briggs P; Cahalin BL; Myers J; Forman DE; Patel MJ; Pinkstaff SO; Arena R
    Prog Cardiovasc Dis; 2015; 58(1):94-101. PubMed ID: 25936908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
    Milani RV; Lavie CJ
    Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 11. Using an ounce of prevention: does it reduce health care expenditures and reap pounds of profits? A study of the financial impact of wellness and health risk screening programs.
    Phillips JF
    J Health Care Finance; 2009; 36(2):1-12. PubMed ID: 20499716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial.
    Coffeng JK; van der Ploeg HP; Castellano JM; Fernández-Alvira JM; Ibáñez B; García-Lunar I; van der Beek AJ; Fernández-Ortiz A; Mocoroa A; García-Leal L; Cárdenas E; Rojas C; Martínez-Castro MI; Santiago-Sacristán S; Fernández-Gallardo M; Mendiguren JM; Bansilal S; van Mechelen W; Fuster V
    Am Heart J; 2017 Feb; 184():121-132. PubMed ID: 28224926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction.
    Maron DJ; Forbes BL; Groves JR; Dietrich MS; Sells P; DiGenio AG
    J Cardiovasc Nurs; 2008; 23(6):513-8. PubMed ID: 18953215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP; Holmes DP
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):587-8. PubMed ID: 22811502
    [No Abstract]   [Full Text] [Related]  

  • 17. A health plan perspective on worksite-based health promotion programs.
    Thygeson NM
    Am J Prev Med; 2010 Feb; 38(2 Suppl):S226-8. PubMed ID: 20117607
    [No Abstract]   [Full Text] [Related]  

  • 18. The history and impact of worksite wellness.
    Reardon J
    Nurs Econ; 1998; 16(3):117-21. PubMed ID: 9748973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worksite wellness: increasing adoption of workplace health promotion programs.
    Michaels CN; Greene AM
    Health Promot Pract; 2013 Jul; 14(4):473-9. PubMed ID: 23545334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting health and wellness in the workplace: a unique opportunity to establish primary and extended secondary cardiovascular risk reduction programs.
    Arena R; Guazzi M; Briggs PD; Cahalin LP; Myers J; Kaminsky LA; Forman DE; Cipriano G; Borghi-Silva A; Babu AS; Lavie CJ
    Mayo Clin Proc; 2013 Jun; 88(6):605-17. PubMed ID: 23726400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.